Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial

Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial

Abstract Background Trimetazidine is a metabolic anti-ischemic agent, which increases the tolerance of cardiomyocytes to ischemia. However, few studies have explored the effect of trimetazidine on ventricular remodeling in coronary artery disease (CAD) patients undergoing percutaneous coronary inter...

Full description

Bibliographic Details
Main Authors: Lili Wu, Yi Luan, Ya Li, Min Wang, Jialin He, Chongying Jin, Wenbin Zhang
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Cardiovascular Disorders
Subjects:
Trimetazidine
Ventricular remodeling
Myocardial ischemia
Online Access:http://link.springer.com/article/10.1186/s12872-020-01557-3

Internet

http://link.springer.com/article/10.1186/s12872-020-01557-3

Similar Items